|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 86.05 CHF | -0.12% |
|
-0.06% | +15.74% |
| 05-29 | GALENICA : Target upgrade by 3.0% |  |
| 05-22 | Swiss Stocks Remain in the Red; Sandoz Shares Edge Down | MT |
| Capitalization | 4.29B 5.24B 4.57B 3.9B 7.2B 455B 8.12B 50.64B 19.55B 207B 19.67B 19.25B 764B | P/E ratio 2025 * |
24.1x | P/E ratio 2026 * | 22.6x |
|---|---|---|---|---|---|
| Enterprise value | 4.86B 5.93B 5.17B 4.42B 8.15B 515B 9.19B 57.32B 22.13B 235B 22.26B 21.78B 864B | EV / Sales 2025 * |
1.19x | EV / Sales 2026 * | 1.14x |
| Free-Float |
99.44% | Yield 2025 * |
2.73% | Yield 2026 * | 2.84% |
More valuation ratios
* Estimated data
More news
Last Transcript: Galenica AG
More recommendations
More press releases
| 1 day | +0.29% | ||
| 1 week | +0.70% | ||
| Current month | +1.35% | ||
| 1 month | -1.93% | ||
| 3 months | +9.30% | ||
| 6 months | +18.45% | ||
| Current year | +16.14% |
| 1 week | 84.95 |  | 87.1 |
| 1 month | 84 | | 89.35 |
| Current year | 74.1 | | 89.35 |
| 1 year | 70.3 | | 89.35 |
| 3 years | 64.85 | | 89.35 |
| 5 years | 57.15 | | 89.35 |
| 10 years | 41.8 | | 89.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marc Werner
CEO | Chief Executive Officer | 58 | 31/03/2020 |
Lukas Ackermann
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/12/2021 |
Marianne Hasler
HRO | Human Resources Officer | 46 | 31/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Bertrand Jungo
BRD | Director/Board Member | 60 | 31/12/2017 |
| Chairman | 67 | 02/05/2023 | |
Pascale Bruderer
BRD | Director/Board Member | 48 | 31/12/2019 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 0.17% | 1,022 M€ | +18.61% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.29% | +0.70% | +16.45% | +33.26% | 5.24B | ||
| -0.14% | +0.06% | +20.79% | +135.52% | 91.2B | ||
| +0.18% | +2.58% | +58.64% | +221.56% | 39.48B | ||
| -2.18% | -2.48% | - | - | 23.91B | ||
| -0.15% | -8.63% | +37.68% | -2.44% | 10.03B | ||
| -0.29% | -5.77% | -9.34% | -4.06% | 8.13B | ||
| +0.88% | -3.96% | -16.75% | -0.97% | 7.27B | ||
| +1.09% | -5.97% | -4.41% | +5.28% | 5.37B | ||
| +0.41% | +0.95% | +15.27% | -5.08% | 4.51B | ||
| -0.40% | -7.71% | -1.95% | +14.13% | 3.5B | ||
| Average | -0.01% | -1.72% | +12.93% | +44.13% | 19.86B | |
| Weighted average by Cap. | -0.16% | +1.30% | +25.84% | +121.74% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4.1B 5B 4.36B 3.73B 6.87B 435B 7.75B 48.35B 18.67B 198B 18.78B 18.37B 729B | 4.24B 5.18B 4.52B 3.86B 7.12B 450B 8.03B 50.07B 19.33B 205B 19.44B 19.03B 755B |
| Net income | 177M 216M 189M 161M 297M 18.78B 335M 2.09B 807M 8.56B 812M 794M 31.52B | 188M 229M 200M 171M 314M 19.89B 355M 2.21B 854M 9.06B 859M 841M 33.37B |
| Net Debt | 566M 690M 602M 514M 949M 59.97B 1.07B 6.67B 2.58B 27.32B 2.59B 2.54B 101B | 525M 640M 558M 477M 880M 55.62B 992M 6.19B 2.39B 25.34B 2.4B 2.35B 93.33B |
More financial data
* Estimated data
Employees
6,241
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/06/25 | 86.05 CHF | -0.12% | 139,063 |
| 19/06/25 | 86.15 CHF | +0.29% | 59,122 |
| 18/06/25 | 85.90 CHF | +0.12% | 60,337 |
| 17/06/25 | 85.80 CHF | -0.58% | 74,406 |
| 16/06/25 | 86.30 CHF | +0.64% | 127,672 |
Delayed Quote Swiss Exchange, June 20, 2025 at 03:47 pm
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
86.15CHF
Average target price
80.75CHF
Spread / Average Target
-6.27%
Annual profits - Rate of surprise
- Stock Market
- Equities
- GALE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition